Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, United States.
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, United States.
Elife. 2023 Jun 20;12:e85792. doi: 10.7554/eLife.85792.
Aging and the age-associated decline of the proteome is determined in part through neuronal control of evolutionarily conserved transcriptional effectors, which safeguard homeostasis under fluctuating metabolic and stress conditions by regulating an expansive proteostatic network. We have discovered the homeodomain-interacting protein kinase (HPK-1) acts as a key transcriptional effector to preserve neuronal integrity, function, and proteostasis during aging. Loss of results in drastic dysregulation in expression of neuronal genes, including genes associated with neuronal aging. During normal aging expression increases throughout the nervous system more broadly than any other kinase. Within the aging nervous system, induction overlaps with key longevity transcription factors which suggests that expression mitigates natural age-associated physiological decline. Consistently, pan-neuronal overexpression of extends longevity, preserves proteostasis both within and outside of the nervous system, and improves stress resistance. Neuronal HPK-1 improves proteostasis through kinase activity. HPK-1 functions cell non-autonomously within serotonergic and γ-aminobutyric acid (GABA)ergic neurons to improve proteostasis in distal tissues by specifically regulating distinct components of the proteostatic network. Increased serotonergic HPK-1 enhances the heat shock response and survival to acute stress. In contrast, GABAergic HPK-1 induces basal autophagy and extends longevity, which requires (MLX), (TFEB), and (FOXO). Our work establishes as a key neuronal transcriptional regulator critical for preservation of neuronal function during aging. Further, these data provide novel insight as to how the nervous system partitions acute and chronic adaptive response pathways to delay aging by maintaining organismal homeostasis.
衰老和与年龄相关的蛋白质组衰退部分是通过神经元控制进化保守的转录效应因子来决定的,这些转录效应因子通过调节广泛的蛋白质稳态网络,在代谢和应激条件波动的情况下保护内稳态。我们发现同源域相互作用蛋白激酶(HPK-1)是一种关键的转录效应因子,可在衰老过程中维持神经元的完整性、功能和蛋白质稳态。缺失会导致神经元基因表达的严重失调,包括与神经元衰老相关的基因。在正常衰老过程中,在神经系统中广泛表达,比任何其他激酶都要广泛。在衰老的神经系统中,的诱导比任何其他激酶都更广泛,与长寿相关的转录因子重叠。这表明 的表达减轻了自然与年龄相关的生理衰退。一致地,在整个神经系统中过表达 可以延长寿命,在神经系统内外都能维持蛋白质稳态,并提高应激抗性。神经元 HPK-1 通过激酶活性改善蛋白质稳态。HPK-1 在 5-羟色胺能和γ-氨基丁酸(GABA)能神经元中发挥细胞非自主性作用,通过特异性调节蛋白质稳态网络的不同组成部分,改善远端组织的蛋白质稳态。增加 5-羟色胺能 HPK-1 可增强热休克反应和对急性应激的生存能力。相比之下,GABA 能 HPK-1 诱导基础自噬并延长寿命,这需要 (MLX)、 (TFEB)和 (FOXO)。我们的工作确立了 作为一个关键的神经元转录调节剂,对于在衰老过程中维持神经元功能至关重要。此外,这些数据提供了新的见解,即神经系统如何通过维持机体的内稳态来分配急性和慢性适应性反应途径,以延缓衰老。